Healthcare -
Biotechnology - NASDAQ - GB
$ 0.5799
-1.71 %
$ 148 M
Market Cap
-3.41
P/E
ADAP - NET INCOME
Net Income ADAP - Adaptimmune Therapeutics plc
-114 M
LAST VALUE
15.13%
2 YEAR CAGR
-3.58%
5 YEAR CAGR
-28.41%
10 YEAR CAGR